al-Shoumer K A, Anyaoku V, Richmond W, Johnston D G
Unit of Metabolic Medicine, Imperial College School of Medicine, St Mary's Hospital, London, UK.
Clin Endocrinol (Oxf). 1997 Aug;47(2):153-9. doi: 10.1046/j.1365-2265.1997.2131054.x.
Hypopituitarism with growth hormone (GH) deficiency is associated with obesity characterized by central (abdominal) distribution of fat. Recent work has demonstrated that leptin, a product of obese gene, is raised in obesity.
To study circulating leptin levels in GH-deficient hypopituitary adults and to investigate its anthropometric, gender and metabolic relations.
After an overnight fast of 10-12 hours, anthropometric parameters and body composition were measured and blood was collected for the measurement of circulating leptin, glucose, intact insulin, proinsulin, IGF-I, total cholesterol, triglycerides, high density lipoprotein (HDL) cholesterol and low density lipoprotein (LDL) cholesterol.
Fifteen (7 men) GH-deficient hypopituitary adults (maximum stimulated serum GH to provocative testing < 6 mU/l) and 21 (10 men) normal control subjects matched for age, gender and body mass index (BMI).
Fasting serum leptin was significantly higher in hypopituitary patients than controls (12.0 +/- 1.8 vs 8.0 +/- 1.5 micrograms/l, P = 0.04). The increase was more marked in obese (BMI > 26.0 kg/m2) patients compared with obese controls (15.3 +/- 2.0 vs 8.8 +/- 2.3 micrograms/l, P = 0.03) than in lean patients and controls. Obese control women and men had higher leptin levels than non-obese (women, 16.6 +/- 2.7 vs 8.6 +/- 0.6 micrograms/l, P = 0.03; men, 4.9 +/- 0.5 vs 2.9 +/- 0.6 micrograms/l, P = 0.035). Similar changes were observed for obese versus non-obese patients, although the changes did not reach statistical significance. Women in each group had significantly higher leptin concentrations than men (patients: 15.5 +/- 2.3 vs 7.3 +/- 1.4 micrograms/l, P = 0.009; controls: 12.6 +/- 2.4 vs 4.3 +/- 0.5 micrograms/l, P = 0.0001). These gender differences remained significant even when expressed in relation to BMI (patients: 0.57 +/- 0.09 vs 0.26 +/- 0.05 ng.m2/ml.kg, P = 0.009; controls: 0.43 +/- 0.05 vs 0.16 +/- 0.02 ng.m2/ml.kg, P = 0.0001). Serum leptin was positively associated with body mass index (P = 0.003), percentage body fat mass (P = 0.0001) and inversely related with age (P = 0.043). It demonstrated no relation with body weight, waist circumference, waist to hip ratio, fasting IGF-I, glucose, insulin, proinsulin, total cholesterol, triglycerides, HDL and LDL cholesterol in patients nor controls; 85% of variance in leptin was explained by a model including body mass index, gender, age and hypopituitarism.
Leptin concentrations are raised in GH-deficient hypopituitary adults to a greater extent than would be expected from the degree of obesity.
伴有生长激素(GH)缺乏的垂体功能减退与以脂肪中心性(腹部)分布为特征的肥胖有关。最近的研究表明,肥胖基因的产物瘦素在肥胖人群中升高。
研究生长激素缺乏的垂体功能减退成年患者的循环瘦素水平,并探讨其与人体测量学、性别及代谢的关系。
在禁食10 - 12小时后,测量人体测量学参数和身体成分,并采集血液以检测循环瘦素、葡萄糖、完整胰岛素、胰岛素原、胰岛素样生长因子-I(IGF-I)、总胆固醇、甘油三酯、高密度脂蛋白(HDL)胆固醇和低密度脂蛋白(LDL)胆固醇。
15名(7名男性)生长激素缺乏的垂体功能减退成年患者(激发试验中最大刺激血清生长激素 < 6 mU/l)和21名(10名男性)年龄、性别及体重指数(BMI)匹配的正常对照者。
垂体功能减退患者的空腹血清瘦素显著高于对照组(12.0 ± 1.8 vs 8.0 ± 1.5微克/升,P = 0.04)。与肥胖对照组(15.3 ± 2.0 vs 8.8 ± 2.3微克/升,P = 0.03)相比,肥胖(BMI > 26.0 kg/m²)患者的升高更为明显,瘦患者和瘦对照组之间差异则不明显。肥胖对照组女性和男性的瘦素水平高于非肥胖者(女性,16.6 ± 2.7 vs 8.6 ± 0.6微克/升,P = 0.03;男性,4.9 ± 0.5 vs 2.9 ± 0.6微克/升,P = 0.035)。肥胖与非肥胖患者之间也观察到类似变化,尽管差异未达到统计学意义。每组女性的瘦素浓度均显著高于男性(患者:15.5 ± 2.3 vs 7.3 ± 1.4微克/升,P = 0.009;对照组:12.6 ± 2.4 vs 4.3 ± 0.5微克/升,P = 0.0001)。即使以BMI表示,这些性别差异仍然显著(患者:0.57 ± 0.09 vs 0.26 ± 0.05 ng.m²/ml.kg,P = 0.009;对照组:0.43 ± 0.05 vs 0.16 ± 0.02 ng.m²/ml.kg,P = 0.0001)。血清瘦素与体重指数(P = 0.003)、体脂百分比(P = 0.0001)呈正相关,与年龄呈负相关(P = 0.043)。在患者和对照组中,它与体重、腰围、腰臀比、空腹IGF-I、葡萄糖、胰岛素、胰岛素原、总胆固醇、甘油三酯、HDL和LDL胆固醇均无相关性;瘦素85%的变异可由一个包括体重指数、性别、年龄和垂体功能减退的模型解释。
生长激素缺乏的垂体功能减退成年患者的瘦素浓度升高幅度大于根据肥胖程度预期的水平。